← 產業報告目錄
Fecal Immunochemical Diagnostic Test (FIT) Market Size, Share & Trends Analysis Report, Product: Kits & Reagents, Analyzers, and Others), By End-user (Hospitals & Diagnostics Laboratories, Specialty Clinics, Home Care Settings and Research Institutes), By Region, Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-21頁數 170報告編號 INSIGHTACE-3df9d1ffb4
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2023 valuation of USD 1.36 Bn, the global Fecal Immunochemical Diagnostic Test (FIT) Market is expected to increase to USD 2.03 Bn by 2031, demonstrating a CAGR of 5.29% during the 2024–2031 forecast window.
The Fecal Immunochemical Diagnostic Test (FIT) sector involves The fecal immunochemical diagnostic test (FIT) represents a non-invasive screening tool that can detect hidden blood in feces, which can be an early sign of colon cancer or other gastrointestinal disorders. This domain has witnessed substantial transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is driven by mounting healthcare spending, technological evolution, and the mounting focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Fecal Immunochemical Diagnostic Test (FIT) Market Snapshot
Chapter 4. Global Fecal Immunochemical Diagnostic Test (FIT) Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product:
5.2.1. Kits & Reagents
5.2.2. Analyzers
5.2.3. Others
Chapter 6. Market Segmentation 2: By End-user Estimates & Trend Analysis
6.1. By End-user & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-user:
6.2.1. Hospitals & Diagnostics Laboratories
6.2.2. Specialty Clinics
6.2.3. Home Care Settings
6.2.4. Research Institutes
Chapter 7. Fecal Immunochemical Diagnostic Test (FIT) Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.1.2. North America Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
7.1.3. North America Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.2. Europe
7.2.1. Europe Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.2.2. Europe Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
7.2.3. Europe Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.3.2. Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
7.3.3. Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.4. Latin America
7.4.1. Asia Pacific Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.4.2. Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
7.4.3. Latin America Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.5.2. Middle East & Africa Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
7.5.3. Middle East & Africa Fecal Immunochemical Diagnostic Test (FIT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Quest Diagnostics Incorporated
8.2.2. Sentinel CH. SpA
8.2.3. FUJIFILM Corporation
8.2.4. Quidel Corporation
8.2.5. Danaher (Beckman Coulter, Inc.)
8.2.6. Eiken Chemical Co., Ltd
8.2.7. Freenome Holdings, Inc.
8.2.8. Immunostics, Inc.
8.2.9. BTNX, Inc.
8.2.10. Biohit Oyj.
8.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們